Ultima Genomics Stock
Ultima Genomics is a developer of a low-cost sequencing platform.
Sign up today and learn more about Ultima Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Ultima Genomics Stock
Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company was founded in 2016 and is based in Newark, California.
Funding History
| May 2022 | $600M |
|---|
Management
CSO
Doron Lipson
Founder & CEO
Gilad Almogy
CCO
Josh Lauer
CTO & Co-Founder
Mark Pratt
CFO
David Peoples
Press
businesswire - Sep, 27 2023
Integrated DNA Technologies Reveals Launch of xGen™ Products for Ultima Genomics®fiercebiotech - Apr, 11 2023
Ultima Genomics combines '$100 genome' tech with Genome Insight's AI-powered analysisnews-medical - Feb, 17 2023
Ultima Genomics partners with New England Biolabs® to expand research applications on Ultima Sequencersbiospace - Feb, 6 2023
Ultima Genomics Announces Collaboration with 10x Genomics to Enable Seamless Integration of Chromium Single Cell Applications on Ultima Sequencersbiospace - Jul, 12 2022
Ultima Genomics signs development agreement with Regeneron aimed at driving the scale of genomic information for drug discovery and developmentnews - Jun, 24 2022
Even A16z Is Slowing Its Investing Paceprnewswire - Jun, 21 2022
Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costsnews - Jun, 13 2022
Which Startup Sectors Are The Bulls And Bears In 2022’s Sluggish VC Market?prnewswire - Jun, 9 2022
Ultima Genomics and Olink collaborate to develop solution for high-throughput proteomicsnews - Jun, 8 2022
Meet The 34 New Unicorn Companies Minted In May 2022news - Jun, 8 2022
Biotech Startup Funding Has Also Slowed In 2022nocamels - Jun, 4 2022
Ultima Genomics Emerges From Steath, Raises $600MEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
